"Ngày 17 tháng 7 năm 1969, được sự đồng ý của Chính phủ, Bộ trưởng Bộ Y tế ra quyết định số 711/QĐ-BYT thành lập Bệnh viện K được thành lập từ tiền thân là Viện Curie Đông Dương (Insitut Curie de L’Indochine) ra đời tại Hà Nội vào ngày 19/10/1923 do Luật sư Mourlan phụ trách.. Bệnh viện với 3 cơ sở khang trang, sạch sẽ và nhiều trang thiết bị hiện đại sánh ngang tầm với các quốc gia trong khu vực. Hiện nay, 3 cơ sở khám chữa bệnh trên địa bàn Hà Nội đó là: Cơ sở 1: Số 43 Quán Sứ, Hoàn Kiếm, Hà Nội và số 9A-9B Phan Chu Trinh, Hoàn Kiếm, Hà Nội. Cơ sở 2: Tựu Liệt, Tam Hiệp, Thanh Trì, Hà Nội. Cơ sở 3: cơ sở Tân Triều, số 30 Cầu Bươu, Thanh Trì, Hà Nội. Theo chỉ tiêu Bộ Y tế giao năm 2015 bệnh viện có 1800 giường bệnh."

During the past decade, National Cancer Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Cancer Hospital" #1 collaborator was "Zai Lab (Shanghai) Co., Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "National Cancer Hospital" are "Breast Cancer" (1 trials), "Breast Cancer Female" (1 trials), "Hepatocellular Carcinoma" (1 trials), "Metastatic Nonsquamous Non-Small Cell Lung Cancer" (1 trials) and "Metastatic Squamous Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "National Cancer Hospital" in a lesser frequency.

Most popular intervention types in "National Cancer Hospital" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab as Avastin" (1 trials), "Bevacizumab as MYL-1402O" (1 trials), "Carboplatin" (1 trials), "Cisplatin" (1 trials) and "Dummy infusion" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Cancer Hospital" are 3 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "National Cancer Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in National Cancer Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in National Cancer Hospital, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".